Advanced Clinical Blog

By

Subscribe Here!

Topic: Clinical Research Monitoring

Clinical Research / Monitoring

Lessons Learned from the pandemic: Adapting risk management in clinical trials
By Melissa Mauriber on December 8, 2020

COVID-19 taught our industry an important lesson about risk mitigation. It forced many sponsors, CROs, and sites to make rapid, unplanned adjustments to their clinical trial operations....

Continue Reading

Clinical Research / Monitoring

Continued Stability for Mid-Market Drug Development in 2021 and Beyond

As 2020 comes to a close, the year will likely be remembered as one of the most, if not the most, challenging times in our personal and professional lives. A rapid global pandemic,...

Continue Reading

Clinical Research / Monitoring Clinical Staffing

3 Ways Marketing Embraced the Pandemic with an Opportunistic, Client-Focused Mindset

The year 2020 was a game changer for so many due to the challenges presented by COVID-19. It also presented life sciences marketing teams with the unique challenge of having to shift...

Continue Reading

Clinical Project Management Clinical Research / Monitoring

How COVID-19 Caused an Increase in Response Rates from Investigative Sites in Europe

The pharmaceutical industry is constantly evolving, and in order to be effective, CROs have to evolve alongside their Sponsors. At Advanced Clinical, that means constantly implementing...

Continue Reading

Patient Recruitment and Retention Clinical Research / Monitoring

5 Tips for Recruiting Patients During a Pandemic
By Domantas Gurevicius on July 22, 2020

COVID-19 may have dramatically disrupted the clinical research environment – but it hasn’t shut us down. Many ongoing studies are continuing to treat patients virtually, while new trials...

Continue Reading

Clinical Research / Monitoring

The Importance of Working with a Stable CRO Partner – From Start to Finish
By Allison Billups on July 10, 2020

Choosing a Contract Research Organization (CRO) is one of the most important decisions a sponsor company – especially a mid-sized biotech company – will make early in the drug...

Continue Reading

Stay up to date